ARCHIVES

FDA, ASCO Meet to Review Drug Approval Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 17 | April 25, 2003

Download PDF Visit The Full Archive

Related Articles

Senate “Pleased” About Reductions In Incidence And Mortality

October 8, 1999

NCAB Hung Up On removing $ 45 Million Limit For Core Grants

September 17, 1976

NCI “Month” Appropriate For May, With Several Major Decisions Pending got Start Next 50 Years

May 1, 1987

Committee To Set Research Agenda On Breast Cancer. Justice Department Appeals Injunction On Stem Cell Research

September 3, 2010

DCT Board Approves More Than $25 Million In Contract Recompetitions, Two New Contracts

February 23, 1990

ACS Challenged To Clarify Position On FDA Reform

March 1, 1996